Loren Wass - Oct 14, 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Chief Commercialization Officer
Signature
/s/ Loren Wass
Stock symbol
BNKL
Transactions as of
Oct 14, 2021
Transactions value $
$0
Form type
4
Date filed
10/18/2021, 05:01 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Employee Stock Option (right to buy) Award $0 +55K $0.00 55K Oct 14, 2021 Common Stock, par value $0.001 55K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 13,750 on the date of grant and on each of October 14, 2022, October 14, 2023 and October 14, 2024.

Remarks:

Chief Commercialization Officer